Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
July-August 2011 Volume 2 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-August 2011 Volume 2 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Establishment of primary mouse lung adenocarcinoma cell culture

  • Authors:
    • Shuli Luo
    • Mei Sun
    • Rui Jiang
    • Guan Wang
    • Xinyi Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Thoracic Surgery, The Second Hospital of Jilin University, Changchun 130041, P.R. China, Department of Pathology, The Second Hospital of Jilin University, Changchun 130041, P.R. China, Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun 130033, P.R. China, Department of Cardiac Medicine, The Second Hospital of Jilin University, Changchun 130041, P.R. China
  • Pages: 629-632
    |
    Published online on: May 9, 2011
       https://doi.org/10.3892/ol.2011.301
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Lung cancer is the most common malignant disease worldwide and is the leading cause of death from cancer. Primary cultures derived from lung cancer are essential for understanding abnormal growth function in lung epithelia. In this study, 2 out of 5 primary lung adenocarcinoma cultures derived from DNA repair-deficient mice were established and characterised using electron microscopy and immunostaining. Results of the tumourigenicity tests confirmed that these primary cells are tumourigenic. In conclusion, an effective primary culture method provides a tool for clinical antitumour drug testing.

Introduction

Lung cancer is the most common malignant disease worldwide, and it is a major cause of death from cancer, particularly among males. Lung cancer almost exclusively involves carcinomas, arising from epithelial tissue of the trachea, bronchi or lung (1). Principal histological types of lung cancer are squamous cell carcinoma, adenocarcinoma, large cell carcinoma (collectively referred to as ‘non-small cell’ lung carcinomas) and small cell carcinoma (2). In addition to smoking, a positive familial history of lung cancer has been identified as a risk factor (3). Genetic alterations associated with lung cancer include frequent mutations in p53 gene, activating point mutations in the KRAS oncogene, frequent loss of heterozygosity and aberrant transcripts of the Fragile Histidine Triad (FHIT) gene, homozygous deletions and transcriptional silencing of the CDK inhibitor p16. Increased risk of lung cancer has been associated with certain polymorphisms of cytochrome P450 genes and with deficiencies in DNA repair capacity including DNA base excision repair genes XRCC1, PARP-1 and ERCC4 (4–6).

DNA damage response emerges as a biological tumourigenesis barrier in the early stages of cancer development, and exerts a selective pressure that favours outgrowth of malignant clones with defects in the genome maintenance machinery (7). Findings of previous studies showed that although wild-type mice rarely develop carcinomas, defective DNA repair in PARP-1 mutant mice leads to malignant epithelial tumours such as those of the lung, liver and mammary gland (8–10). To gain a better understanding of the role of DNA repair defects in lung carcinogenesis and to establish a primary culture method for anti-cancer drug screening primary mouse lung carcinoma cells were isolated from PARP-1 mutant mice.

Materials and methods

Primary cultures

For primary cell-culture experiments, lung tumours obtained from PARP-1 deficient mice (from the Jackson laboratory, Bar Harbor, ME, USA) at various ages were processed within 30 min after biopsy removal. Tumour specimens were cut into 1-mm slices in order that single cells as well as cell clumps (organoids) be released into the washing medium. Larger clumps were separated by allowing them to gravity settle for a few minutes. The clumps were reduced in size by gentle rotation in a test tube for 30–60 min. Cells and organoids isolated in this way were directly used for primary cultures, as described below. The remaining tissue slices were routinely subjected to enzymatic digestion with 0.3 mg/ml collagenase (Sigma, St. Louis, MO, USA) by gentle agitation for 1 to 2 h at 37°C in DMEM containing 5% FCS, 200 U/ml penicillin, 200 μg/ml streptomycin, 50 μg/ml gentamycin and 50 U/ml nystatin. The procedure involved for the establishment of cell cultures was as previously described (11–13), and was adapted for the processing of mouse lung carcinoma.

Isolated cells and cell clumps were routinely seeded onto round glass coverslips in growth medium I containing 10% FCS, 4.0 mM glutamine, 10 mM HEPES, 100 U/ml penicillin, 100 μg/ml streptomycin, 50 μg/ml gentamycin, 50 U/ml nystatin, 1 μg/ml hydrocortisone (Sigma), 0.2 U/ml insulin (Sigma), 2 μg/ml transferring (Sigma) and 5 nM sodium selenite (Sigma). After 1 week the medium was replaced by growth medium II (as above, without gentamycin and nystatin). Only those cultures in which fibroblast contamination was low, and in which overgrowth of epithelial cells by fibroblasts became unlikely, were processed further. Growth medium III was used (DMEM plus 10% heat-inactivated FCS, 50 U/ml penicillin, 50 μg/ml streptomycin, 4.0 mM glutamine and 10 mM HEPES). All cell culture media and reagents were purchased from Life Sciences Technologies (Blowing Rock, NC, USA).

Since fibroblast-conditioned medium appears to support growth of intestinal epithelial cells, preferential growth of epithelial cells without fibroblast overgrowth was initiated on glass coverslips by using mouse primary fibroblast cells (MPFs) lethally irradiated with 60 Gray (6,000 rads) of γ radiation (IBL-437C, CIS Bio, Gif-Sur-Yvette, France). MPFs were seeded as a feeder layer in the tissue-culture plate on which glass coverslips were placed. Feeder layers were used at 30–40% confluency and were maintained for 1 week. Alternatively, MPFs-culture supernatants were mixed 1:1 with fresh growth medium II (conditioned growth medium). For initial passaging, primary cultures were sub-cultured only when areas of tumour cell growth became confluent. For the first passage, all cells from a coverslip were mechanically scraped off and transferred to a fresh culture plate with conditioned growth medium. Fibroblast growth had to be continuously suppressed in cultures by using conditioned growth medium. Cellular morphology in the primary cultures was evaluated by light microscopy. The epithelial nature was characterised with electron microscopy and by immuostaining.

Electron microscopy and immunostaining

For scanning electron microscopy and transmission electron microscopy, as well as for immunostaining, cells were seeded on round glass coverslips. At the end of the culture time cells were washed in phosphate-buffered saline and fixed for 2 h in 2.5% glutaraldehyde in cacodylate buffer and processed by routine methods for electron microscopic examination. For immunostaining, cells were fixed with paraformaldhyde, incubated with monoclonal antibodies against pan-cytokeratins (NovoCastra, Newcastle, UK) and β-catenin (Cell Signaling, USA) or Cy3-conjugated anti-IgG antibody (Cappel, Organon, NC, USA). Glass coverslips were mounted upside-down in Vectashield mounting medium (Vector, Burlingame, CA, USA).

Tumourigenicity test

For the tumourigenicity test, cells were cultured to 70% confluence and trypsinised into single cell suspension. LC1 and LC2 (1×106) cells were inoculated subcutaneously into 5 immunocompromised nude mice (Balb/C) and maintained for two weeks. Tumours were collected and subjected to histological examination. The experimental protocols were approved by the Ethics Committee of the Second Bethune Hospital of Jilin University.

Histology and immunohistochemistry

Histological analysis was carried out on 3-μm sections stained with haematoxylin and eosin, or immunostained (11–13). Antibodies included anti-pan-cytokeratin (NovoCastra) and E-cadherin (Chemicon International, Temecula, CA, USA).

Results

Primary cultures derived from mouse lung adenocarcinomas

By introducing modifications to previously published methods (13), i.e., using collagenase and shorter time periods for enzymatic digestion, as well as MPFs-conditioned growth medium for maintaining optimal growth of epithelial cells, viable adherent primary cultures were successfully established for propagation in 2 out of 5 cases (40%) of surgically obtained malignant tumours. Cells from 3 cases failed to passage, although the cells initially attached and started to form colonies in the first 2 weeks of culture. Tumour samples were considered to be moderately or well-differentiated. Notably, no correlation was found between histological grading or staging and success in establishing primary cultures. In all adherent cultures, cell migration from organoids was evident within 7 days of initiation, with 2 cultures proliferating for several months. Two primary cells (LC1 and LC2) were sub-cultured by mechanical scraping within 1–3 months of the initiation of cultures (Fig. 1A and D), whereas fibroblasts remain attached. LC1 and LC2 subcultures between passages 3 and 6 were used to check the epithelial nature of passaged cells by electron microscopy and by immunostaining of cytokeratin and β-catenin (Figs. 1 and 2).

Figure 1

Electron microscopic analysis of primary cultured mouse lung adenocarcinoma cells. (A) and (D) Low magnification of LC1 and LC2 cells, respectively. (B) and (E) Scanning electron micrograph of LC1 and LC2 cells showing compacted, pavement-like cells with dense (LC1) and less dense (LC2) microvilli on the surface. (C) and (F) Transmission electron micrograph showing junction and microvilli of primary LC1 and LC2 cells. Bar, 75 μm in (A) and (D); 30 μm in (B) and (E); and 10 μm in (C) and (F).

Figure 2

Epithelial nature of primary cultured mouse lung adenocarcinoma cells. (A) A heterogeneous positive pan-cytokeratin immunostaining for LC1 and LC2 cells, DAPI stained for nuclear content. (B) Positive β-catenin immunoactivity for LC1 and LC2 cells.

Cellular morphology

In two primary cultures, cells grew in monolayers, though in varying degrees of attachment to the plastic support. Cells were polarized, exhibiting junctional complexes and microvilli, albeit with large differences in number and organisation even between cells in the same culture (Figs. 1 and 2). A scanning electron micrograph of a primary culture of a mouse lung carcinoma showed that the majority of polarized cuboidal cells were tightly packed and densely decorated at the apical aspect with well-developed microvilli (Fig. 1B). However, the same culture also contained a number of cells of an epithelial nature that exhibited few or no microvilli (Fig. 1E). A transmission electron micrograph of a primary culture of a mouse lung carcinoma showed a typical epithelial nature as visualized by their decoration to a greater or lesser extent with microvilli (Fig. 1C and F).

Epithelial characters of primary cultured cells were further evaluated using antibodies specific to epithelial markers. Immunocytochemical staining of primary cells revealed strong positive staining for pan-cytokeratin (Fig. 2A) and β-catenin (Fig. 2B). Cells appeared heterogeneous in size at the edge of the cell patch (Fig. 2), and various expression levels of pan-cytokeratin between cells in the same culture were frequently observed (Fig. 2A).

Primary cultured cells are tumourigenic

To evaluate whether primary cells were tumourigenic, LC1 or LC2 (1×106) cells per mouse were inoculated subcutaneously for two weeks. The mice developed tumours within two weeks, and tumour size was between 5 and 10 mm in diameter (Fig. 3A). Histological analysis revealed the inoculated solid tumours to be more or less dense, with compacted cells (Fig. 3B) expressing various levels of pan-cytokeratin and E-cadherin immunoactivity, indicating their epithelial origin.

Figure 3

Tumourigenicity test. (A) Primary cells inoculated subcutaneously into the left inguinal of BALB/c nude mice for two weeks; tumours were detected in all mice (arrows). (B) Histological analysis of tumours and immunohistochemical staining for pan-cytokeratin and E-cadherin. Bar, 400 μm.

Discussion

The majority of mouse lung tumours were well- or moderately differentiated adenocarcinomas utilized for the reproducibility and optimal establishment of primary cultures. Subsequently, short periods of enzymatic digestion and seeding at high density were used. Since fibroblast contamination presents severe difficulties in the establishment of primary cultures, various methods were adopted in this study in order to obtain cells of a purely epithelial nature. Mouse fibroblast feeder layers and fibroblast-conditioned media apparently supported the preferential growth of epithelial cells. Thus, our method of organoid isolation and selective cultivation of epithelial cells on glass coverslips in petri dishes with mouse fibroblast feeder cells protected against fibroblast overgrowth.

Primary cell growth results in the formation of colonies. For passage initiation, the advantages of mechanical scraping are two-fold. First, the cell sheets are released, allowing cells to attach to fresh culture plates more slowly than single cells. Second, replating the cell clumps a few hours after culture into fresh culture plates also protects against fibroblast contamination. Individual mouse lung adenocarcinomas exhibit pronounced regional phenotypic heterogeneity, resulting from the accumulation of specific genetic lesions in different parts of the same tumour.

Although various methods have been used in clinical anti-cancer drug screening (14–16), this study simplified the primary culture protocol and most of the primary cells were cultured and maintained for 2 weeks. Consequently, if the extent of responsiveness of a given tumour to a specific anti-cancer drug is studied in an in vitro model, it should reflect the cellular diversity of the tumour from which it was derived (11–12,17). In this respect, it is of note that the primary cultures described in the present study contain distinct sub-populations of epithelial cells. For instance, the density and the forms of microvilli on the apical plasma membrane were not uniform in a single culture. This may indicate differences in cellular functions as well as differentiation, and allow investigation of the mechanisms of DNA damage response in tumourigenesis (7).

Our results demonstrate the usefulness of the culture model employed in this study for further applications of personalized medicine of primary cultures of human lung adenocarcinoma cells in anti-cancer drug screening (18–20), and for the improvement of personalized drug response. Additionally, primary cultures may be useful in adjuvant therapy of human lung cancer.

Acknowledgements

This study was in part supported by grants from the Natural Science Foundation of China (No. 30870354), Project of Scientific Innovation and Creative for Jilin Provincial Oversea Scholars (No. 2010273), and Jilin Provincial Science & Technology Services (No. 200805120 & No. 20090732).

References

1 

Stewart BW and Kleihues P: World Cancer Report. IARC Press; Lyon: pp. 1822003

2 

Butnor KJ and Beasley MB: Resolving dilemmas in lung cancer staging and histologic typing. Arch Pathol Lab Med. 131:1014–1015. 2007.PubMed/NCBI

3 

Mulshine JL and Henschke CI: Prospects for lung-cancer screening. Lancet. 355:592–593. 2000. View Article : Google Scholar : PubMed/NCBI

4 

Wright GS and Gruidl ME: Early detection and prevention of lung cancer. Curr Opin Oncol. 12:143–148. 2000. View Article : Google Scholar : PubMed/NCBI

5 

Zhang X, Miao X, Liang G, et al: Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res. 65:722–726. 2005.PubMed/NCBI

6 

Shao M, Ma H, Wang Y, et al: Polymorphisms in excision repair cross-complementing group 4 (ERCC4) and susceptibility to primary lung cancer in a Chinese Han population. Lung Cancer. 60:332–339. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Bartek J, Lukas J and Bartkova J: DNA damage response as an anti-cancer barrier: damage threshold and the concept of ‘conditional haploinsufficiency’. Cell Cycle. 6:2344–2347. 2007.PubMed/NCBI

8 

Tong WM, Cortes U, Hande MP, et al: Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res. 62:6990–6996. 2002.PubMed/NCBI

9 

Tong WM, Yang YG, Cao WH, et al: Poly(ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice. Oncogene. 26:3857–3867. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Tong W-M, Hande MP, Lansdorp PM and Wang ZQ: DNA-strand break-sensing molecule PARP cooperates with p53 in telomere function, chromosomal stability and tumour suppression. Mol Cell Biol. 21:4046–4054. 2001. View Article : Google Scholar : PubMed/NCBI

11 

Wang CG, Sun M, Zhao XJ and Zhang XY: Effect of STAT3 siRNA-induced inhibition of STAT3 gene expression on the growth and apoptosis of Lewis lung cancer cells. Chin J Clin Oncol. 3:392–399. 2006. View Article : Google Scholar

12 

Wang CG, Wang RY, Sun M, et al: In vivo antitumour effect of siRNA against STAT3 on transplanted Lewis lung cancer in mice. Chem Res Chin Univ. 24:322–329. 2008.

13 

Tong WM, Ohgaki H, Huang H, Granier C, Kleihues P and Wang ZQ: Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(−/−) mice. Am J Pathol. 162:343–352. 2003.PubMed/NCBI

14 

Yang S, Su J, Cao J, Zhang P, Lu J and Xie W: Establishment of a novel Chinese human lung adenocarcinoma cell line CPA-Yang1 which produces highly bone metastases in immunodeficient mice. Zhongguo Fei Ai Za Zhi. 12:753–759. 2009.PubMed/NCBI

15 

Yaghi A, Zaman A and Dolovich M: Primary human bronchial epithelial cells grown from explants. J Vis Exp. 26:pii1789. View Article : Google Scholar

16 

Kalinina T, Gungor C, Thieltges S, et al: Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. BMC Cancer. 10:2952010. View Article : Google Scholar : PubMed/NCBI

17 

Higashiyama M, Oda K, Okami J, et al: Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients. Lung Cancer. 68:472–477. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Camps C, Sirera R, Iranzo V, Taron M and Rosell R: Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy. Clin Lung Cancer. 8:369–375. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Hardwicke MA, Oleykowski CA, Plant R, et al: GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumour activity in tissue culture cells and human tumour xenograft models. Mol Cancer Ther. 8:1808–1817. 2009. View Article : Google Scholar

20 

Powell C, Mikropoulos C, Kaye SB, et al: Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers. Cancer Treat Rev. 36:566–575. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Luo S, Sun M, Jiang R, Wang G and Zhang X: Establishment of primary mouse lung adenocarcinoma cell culture. Oncol Lett 2: 629-632, 2011.
APA
Luo, S., Sun, M., Jiang, R., Wang, G., & Zhang, X. (2011). Establishment of primary mouse lung adenocarcinoma cell culture. Oncology Letters, 2, 629-632. https://doi.org/10.3892/ol.2011.301
MLA
Luo, S., Sun, M., Jiang, R., Wang, G., Zhang, X."Establishment of primary mouse lung adenocarcinoma cell culture". Oncology Letters 2.4 (2011): 629-632.
Chicago
Luo, S., Sun, M., Jiang, R., Wang, G., Zhang, X."Establishment of primary mouse lung adenocarcinoma cell culture". Oncology Letters 2, no. 4 (2011): 629-632. https://doi.org/10.3892/ol.2011.301
Copy and paste a formatted citation
x
Spandidos Publications style
Luo S, Sun M, Jiang R, Wang G and Zhang X: Establishment of primary mouse lung adenocarcinoma cell culture. Oncol Lett 2: 629-632, 2011.
APA
Luo, S., Sun, M., Jiang, R., Wang, G., & Zhang, X. (2011). Establishment of primary mouse lung adenocarcinoma cell culture. Oncology Letters, 2, 629-632. https://doi.org/10.3892/ol.2011.301
MLA
Luo, S., Sun, M., Jiang, R., Wang, G., Zhang, X."Establishment of primary mouse lung adenocarcinoma cell culture". Oncology Letters 2.4 (2011): 629-632.
Chicago
Luo, S., Sun, M., Jiang, R., Wang, G., Zhang, X."Establishment of primary mouse lung adenocarcinoma cell culture". Oncology Letters 2, no. 4 (2011): 629-632. https://doi.org/10.3892/ol.2011.301
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team